Hormone Replacement Therapy as a Risk Factor for Non-Small Cell Lung Cancer: Results of a Case-Control Study

Publisher： Karger

E-ISSN： 1423-0232|73|5-6|305-310

ISSN： 0030-2414

Source： Oncology, Vol.73, Iss.5-6, 2008-05, pp. : 305-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Case of Stage IV Non-Small Cell Lung Cancer Treated with Korean Medicine Therapy Alone

By  

Case Reports in Oncology, Vol. 6, Iss. 3, 2013-11 ,pp. : 574-578

Karger

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Inhibition and Non-Small Cell Lung cancer

By von Eyben Finn  

Critical Reviews in Clinical Laboratory Sciences, Vol. 43, Iss. 4, 2006-08 ,pp. : 291-323

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 12, 2010-11 ,pp. : 704-709

Karger

Access to resources Recommend Favorite

Chemotherapy in Non-Small Cell Lung Cancer Patients Receiving Oxygen Therapy

By  

Oncology Research and Treatment, Vol. 39, Iss. 10, 2016-09 ,pp. : 587-590

Karger

Access to resources Recommend Favorite

First-Line Therapy of Mutated Non-Small Cell Lung Cancer: An Update

By  

Oncology Research and Treatment, Vol. 35, Iss. 5, 2012-04 ,pp. : 293-299

Karger

Access to resources Recommend Favorite